Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Ovarian Epithelial

Explore clinical trials studying Carcinoma, Ovarian Epithelial. Study availability and eligibility vary by location and protocol.

532 public trials 64 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Ovarian Epithelial trial results

Completed

A Phase II, Open-Label Study Evaluating the Effect Of GW786034 In Subjects With Ovarian Cancer

NCT00281632

Conditions
Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +22 more
Locations
  • GSK Investigational Site Atlanta, Georgia, United States
  • GSK Investigational Site Austin, Texas, United States
  • GSK Investigational Site Bedford, Texas, United States
  • GSK Investigational Site Dallas, Texas, United States
View Trial Details
Completed

Cediranib Maleate in Treating Patients With Persistent, Recurrent, or Refractory Advanced Ovarian Epithelial, Peritoneal Cavity, or Fallopian Tube Cancer

NCT00278343

Conditions
Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +21 more
Locations
  • City of Hope Duarte, California, United States
  • University of Southern California/Norris Cancer Center Los Angeles, California, United States
  • City of Hope Medical Group Inc Pasadena, California, United States
  • University of California at Davis Cancer Center Sacramento, California, United States
View all 28 locations
View Trial Details
Completed

Topotecan in Treating Patients With Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer

NCT00114166

Conditions
Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +21 more
Locations
  • Saint Francis/Mount Sinai Regional Cancer Center at Saint Francis Hospital and Medical Center Hartford, Connecticut, United States
  • George Bray Cancer Center at the Hospital of Central Connecticut - New Britain Campus New Britain, Connecticut, United States
  • Tunnell Cancer Center at Beebe Medical Center Lewes, Delaware, United States
  • CCOP - Christiana Care Health Services Newark, Delaware, United States
View all 78 locations
View Trial Details
Completed

Mifepristone in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer

NCT00459290

Conditions
Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +21 more
Locations
  • Kaiser Permanente Medical Center - Los Angeles Los Angeles, California, United States
  • Saint Francis/Mount Sinai Regional Cancer Center at Saint Francis Hospital and Medical Center Hartford, Connecticut, United States
  • George Bray Cancer Center at the Hospital of Central Connecticut - New Britain Campus New Britain, Connecticut, United States
  • Hinsdale Hematology Oncology Associates Hinsdale, Illinois, United States
View all 22 locations
View Trial Details
Completed

Docetaxel, Trabectedin, and G-CSF or Pegfilgrastim in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer

NCT00569673

Conditions
Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +21 more
Locations
  • Providence Saint Joseph Medical Center - Burbank Burbank, California, United States
  • Jonsson Comprehensive Cancer Center at UCLA Los Angeles, California, United States
  • George Bray Cancer Center at the Hospital of Central Connecticut - New Britain Campus New Britain, Connecticut, United States
  • Tunnell Cancer Center at Beebe Medical Center Lewes, Delaware, United States
View all 37 locations
View Trial Details

Related conditions